Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Canada.
Division of Cardiology, Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, Ottawa, Canada.
Sci Rep. 2023 Jun 8;13(1):9320. doi: 10.1038/s41598-023-36512-7.
Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. In view of the key metabolic role of TRIB1 and the impact of proteasome inhibition on hepatic function, we continue our exploration of TRIB1 regulation in two commonly used human hepatocyte models, transformed cell lines HuH-7 and HepG2. In both models, proteasome inhibitors potently upregulated both endogenous and recombinant TRIB1 mRNA and protein levels. Increased transcript abundance was unaffected by MAPK inhibitors while ER stress was a weaker inducer. Suppressing proteasome function via PSMB3 silencing was sufficient to increase TRIB1 mRNA expression. ATF3 was required to sustain basal TRIB1 expression and support maximal induction. Despite increasing TRIB1 protein abundance and stabilizing bulk ubiquitylation, proteasome inhibition delayed but did not prevent TRIB1 loss upon translation block. Immunoprecipitation experiments indicated that TRIB1 was not ubiquitylated in response to proteasome inhibition. A control bona fide proteasome substrate revealed that high doses of proteasome inhibitors resulted in incomplete proteasome inhibition. Cytoplasm retained TRIB1 was unstable, suggesting that TRIB1 lability is regulated prior to its nuclear import. N-terminal deletion and substitutions were insufficient to stabilize TRIB1. These findings identify transcriptional regulation as a prominent mechanism increasing TRIB1 abundance in transformed hepatocyte cell lines in response to proteasome inhibition and provide evidence of an inhibitor resistant proteasome activity responsible for TRIB1 degradation.
TRIB1 同源物 1(TRIB1)通过促进同源货物的蛋白酶体降解来有助于脂质和葡萄糖的体内平衡。鉴于 TRIB1 的关键代谢作用以及蛋白酶体抑制对肝功能的影响,我们继续在两种常用的人肝细胞模型,转化细胞系 HuH-7 和 HepG2 中探索 TRIB1 的调节。在这两种模型中,蛋白酶体抑制剂强烈地上调内源性和重组 TRIB1 mRNA 和蛋白水平。MAPK 抑制剂对增加的转录丰度没有影响,而 ER 应激的诱导作用较弱。通过 PSMB3 沉默抑制蛋白酶体功能足以增加 TRIB1 mRNA 表达。ATF3 是维持基础 TRIB1 表达和支持最大诱导所必需的。尽管蛋白酶体抑制增加了 TRIB1 蛋白丰度并稳定了总体泛素化,但它延迟了但并没有阻止翻译阻断后 TRIB1 的丢失。免疫沉淀实验表明,TRIB1 没有响应蛋白酶体抑制而被泛素化。一个控制的真正的蛋白酶体底物表明,高剂量的蛋白酶体抑制剂导致不完全的蛋白酶体抑制。细胞质中保留的 TRIB1 不稳定,这表明 TRIB1 的不稳定性在其核输入之前受到调节。N 端缺失和取代不足以稳定 TRIB1。这些发现表明,转录调节是一种重要机制,可在响应蛋白酶体抑制时增加转化肝细胞系中 TRIB1 的丰度,并提供了证据表明存在一种抑制剂抗性的蛋白酶体活性,负责 TRIB1 的降解。